Xiaobin Wu is President & COO at BeiGene, Ltd. (BGNE). They have made 34 open-market trades across 3 companies since 2015, most recently 2026-08-25.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 34 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONC | 1,308,161 | $483.1M |
| BGNE | 5,083 | $939K |
| Total | $484.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONC | SELL · 10b5-1 | 2026-08-25 | 2026-08-27 | $380.00 | $106K | -5.1% | -0.7% | — |
| ONC | SELL | 2026-06-23 | 2026-06-25 | $276.26 | $357K | +9.5% | +18.2% | +32.5% |
| ONC | SELL | 2026-06-16 | 2026-06-18 | $266.76 | $362K | +8.8% | +16.2% | +30.5% |
| ONC | SELL | 2026-06-11 | 2026-06-15 | $261.20 | $164K | +4.9% | +16.8% | +32.7% |
| ONC | SELL | 2026-06-08 | 2026-06-10 | $269.37 | $400K | +7.0% | +15.6% | +36.1% |
| ONC | SELL | 2025-11-17 | 2025-11-19 | $380.43 | $3.0M | -8.8% | -12.7% | -1.9% |
| ONC | SELL | 2025-11-12 | 2025-11-14 | $365.52 | $11.4M | -9.9% | -17.8% | -8.4% |
| ONC | SELL · 10b5-1 | 2025-08-13 | 2025-08-15 | $304.97 | $48.6M | -6.6% | +3.4% | +14.6% |
| ONC | SELL | 2025-06-23 | 2025-06-25 | $260.00 | $354K | -7.0% | +10.9% | +25.2% |
| ONC | SELL | 2025-06-16 | 2025-06-18 | $261.16 | $1.1M | +0.3% | +20.5% | +33.8% |
| ONC | SELL | 2025-06-06 | 2025-06-10 | $253.43 | $549K | -1.0% | -2.5% | +33.3% |
| BGNE | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $281.39 | $29.2M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-03-05 | 2025-03-07 | $261.58 | $27.1M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2025-02-18 | 2025-02-20 | $240.46 | $25.0M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2024-09-17 | 2024-09-19 | $200.13 | $1.9M | +12.3% | +6.9% | -14.5% |
| BGNE | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $189.54 | $2.0M | +2.4% | +26.0% | +3.3% |
| BGNE | SELL | 2024-06-24 | 2024-06-26 | $159.68 | $398K | +1.6% | +14.2% | +47.1% |
| BGNE | SELL | 2024-06-17 | 2024-06-20 | $154.73 | $817K | -6.2% | +4.9% | +28.6% |
| BGNE | SELL | 2023-06-26 | 2023-06-27 | $182.37 | $545K | +8.4% | +17.9% | +7.2% |
| BGNE | SELL | 2023-06-20 | 2023-06-20 | $192.44 | $675K | -6.2% | +1.5% | +9.9% |
| BGNE | SELL | 2023-06-07 | 2023-06-09 | $224.73 | $1.5M | -14.7% | -11.7% | -10.9% |
| BGNE | SELL | 2023-05-08 | 2023-05-10 | $253.72 | $1.8M | -0.7% | -11.4% | -21.4% |
| BGNE | SELL | 2022-06-17 | 2022-06-22 | $142.63 | $453K | +24.9% | +16.0% | -1.2% |
| BGNE | SELL | 2022-06-06 | 2022-06-08 | $141.99 | $968K | -2.0% | +21.2% | +5.0% |
| BGNE | SELL | 2022-05-05 | 2022-05-06 | $163.98 | $1.7M | -6.6% | -1.4% | +36.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.